Insufficient scRNA-seq data for expression of NEURL3 at single-cell level.
Insufficient scRNA-seq data for expression of NEURL3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 1007.39 | 328 / 328 | 89% | 13.19 | 158 / 178 |
kidney | 100% | 591.57 | 89 / 89 | 87% | 4.67 | 781 / 901 |
liver | 98% | 99.31 | 221 / 226 | 73% | 15.39 | 297 / 406 |
prostate | 95% | 298.13 | 232 / 245 | 76% | 2.91 | 381 / 502 |
brain | 78% | 25.09 | 2065 / 2642 | 64% | 1.80 | 452 / 705 |
lung | 85% | 152.86 | 490 / 578 | 44% | 1.96 | 512 / 1155 |
breast | 63% | 164.87 | 290 / 459 | 58% | 2.41 | 651 / 1118 |
intestine | 46% | 35.92 | 441 / 966 | 70% | 3.27 | 368 / 527 |
stomach | 29% | 10.55 | 103 / 359 | 76% | 4.90 | 216 / 286 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.64 | 1 / 1 |
spleen | 95% | 48.66 | 228 / 241 | 0% | 0 | 0 / 0 |
skin | 54% | 31.64 | 983 / 1809 | 36% | 1.01 | 170 / 472 |
esophagus | 12% | 3.98 | 177 / 1445 | 69% | 3.70 | 126 / 183 |
tonsil | 0% | 0 | 0 / 0 | 78% | 4.88 | 35 / 45 |
ovary | 6% | 1.34 | 11 / 180 | 66% | 1.84 | 282 / 430 |
uterus | 9% | 1.92 | 16 / 170 | 61% | 2.98 | 278 / 459 |
bladder | 14% | 4.90 | 3 / 21 | 50% | 2.76 | 253 / 504 |
lymph node | 0% | 0 | 0 / 0 | 38% | 0.93 | 11 / 29 |
peripheral blood | 29% | 212.58 | 271 / 929 | 0% | 0 | 0 / 0 |
heart | 29% | 7.39 | 247 / 861 | 0% | 0 | 0 / 0 |
thymus | 5% | 1.03 | 35 / 653 | 14% | 1.62 | 87 / 605 |
blood vessel | 19% | 5.59 | 259 / 1335 | 0% | 0 | 0 / 0 |
adipose | 19% | 5.56 | 231 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 10% | 4.16 | 25 / 258 | 6% | 0.14 | 14 / 230 |
muscle | 12% | 2.32 | 93 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 6% | 0.10 | 5 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0070086 | Biological process | ubiquitin-dependent endocytosis |
GO_0045087 | Biological process | innate immune response |
GO_0005769 | Cellular component | early endosome |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | NEURL3 |
Protein name | Neuralized E3 ubiquitin protein ligase 3 E3 ubiquitin-protein ligase NEURL3 (EC 2.3.2.27) (Lung-inducible neuralized-related C3CH4 RING domain protein) (Neuralized-like protein 3) (RING-type E3 ubiquitin transferase NEURL3) |
Synonyms | LINCR |
Description | FUNCTION: E3 ubiquitin-protein ligase that plays a role in various biological processes such as lung development or innate immunity . Seems to utilize UBE2E1. Promotes innate antiviral response by catalyzing 'Lys-63'-linked ubiquitination of IRF7 . Inhibits also hepatitis C virus assembly by directly binding to viral E1 envelope glycoprotein to disrupt its interaction with E2 . . |
Accessions | ENST00000435380.3 Q96EH8 ENST00000310865.7 ENST00000451794.6 A0A087WVI2 A0A087WXE0 |